Iranian Journal of
Diabetes and Metabolism
Thu, Sep 12, 2024
|
فارسی
[
Archive
]
Remember me
Create Account
Reset Password
Home
Journal Information
About Journal
Aims & Scope
Editorial Board
Issues
All Issues
Current Issue
Indexing & Abstracting
For Authors
Submission Instruction
Submission Form
Peer Review Policy
Ethical Consideration
Publication Ethics and Malpractice Statement
For Reviewers
Registration
Registration Form
Contact us
Contact Information
Contact us
Volume 10, Issue 3 (17 2011)
ijdld 2011, 10(3): 291-298
|
Back to browse issues page
Download citation:
BibTeX
|
RIS
|
EndNote
|
Medlars
|
ProCite
|
Reference Manager
|
RefWorks
Send citation to:
Mendeley
Zotero
RefWorks
اثربخشی ریپاگلیناید (Novo Norm, Novo Nordisk) در درمان دیابت ملیتوس پس از پیوند کلیه. ijdld 2011; 10 (3) :291-298
URL:
http://ijdld.tums.ac.ir/article-1-122-en.html
اثربخشی ریپاگلیناید (Novo Norm, Novo Nordisk) در درمان دیابت ملیتوس پس از پیوند کلیه
Abstract:
(9918 Views)
This article has no abstract.
Full-Text
[PDF 255 kb]
(2697 Downloads)
Type of Study:
Research
| Subject:
General
Received: 2010/09/19 | Accepted: 2011/01/7 | Published: 2013/10/22
Add your comments about this article : Your username or Email:
Rights and permissions
This work is licensed under a
Creative Commons Attribution-NonCommercial 4.0 International License
.